What is Foxtale?
Foxtale operates as a community-first skincare brand, distinguishing itself through a commitment to efficacy and accessibility. By focusing on scientifically-backed formulations, the company addresses specific dermatological concerns while maintaining a price point that resonates with a broad consumer base. As a D2C brand, Foxtale utilizes direct engagement to foster brand loyalty and gather real-time feedback, allowing for rapid product iteration and a highly responsive supply chain. Its market position is defined by the intersection of clinical-grade skincare and consumer-centric retail, effectively bridging the gap between premium dermatological products and affordable daily essentials.
How much funding has Foxtale raised?
Foxtale has raised a total of $66.7M across 5 funding rounds:
Angel/Seed
$729K
Unspecified
$4M
Other Financing Round
$14M
Series B
$18M
Series C
$30M
Angel/Seed (2021): $729K with participation from Matrix Partners India
Unspecified (2022): $4M, investors not publicly disclosed
Other Financing Round (2024): $14M supported by Panthera Group, Kae Capital, and Matrix Partners India
Series B (2024): $18M featuring Kae Capital and Matrix Partners India
Series C (2025): $30M backed by Kae Capital, KOSÉ, and Panthera Growth Partners
Key Investors in Foxtale
Kae Capital
Kae Capital is a pioneer of early-stage investing in India, specializing in tech startups and operating for over 10 years. The firm is sector-agnostic and partners with passionate founders to build enduring companies for both Indian and global markets.
Matrix Partners India
Matrix Partners India is an investment firm with approximately $1 billion under management, focusing on companies targeting the Indian consumer and enterprise market at the seed, early, and early growth stages.
KOSÉ
KOSE Corporation offers a wide range of skincare, makeup, and haircare products designed to address various beauty concerns, catering to customers looking for effective and innovative solutions in personal care.
What's next for Foxtale?
With the successful closure of this major enterprise-level funding, Foxtale is poised to enter a new phase of operational scaling. The strategic allocation of these funds will likely prioritize the expansion of its product portfolio, enhancement of its digital distribution infrastructure, and the deepening of its community-driven marketing initiatives. As the brand matures, the focus will shift toward sustaining high-growth metrics while maintaining the rigorous quality standards that have defined its early success. Investors are expected to play a pivotal role in providing the necessary industry connections and operational guidance to navigate the complexities of the evolving global beauty market.
See full Foxtale company page
